Join
Live feed
·
INSIDERFilingvia Quantisnow
Kiniksa Pharmaceuticals International plc logo

CHIEF FINANCIAL OFFICER Ragosa Mark sold $502,680 worth of Class A Ordinary Share (12,000 units at $41.89), decreasing direct ownership by 39% to 19,086 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KNSA (Kiniksa Pharmaceuticals International plc) and more on Quantisnow.

CHIEF FINANCIAL OFFICER Ragosa Mark sold $502,680 worth of Class A Ordinary Share (12,000 units at $41.89), decreasing direct ownership by 39% to 19,086 units (SEC Form 4) | Quantisnow